Open AccessODAC Backs FDAʼs Strong Stance on Need for Post-Marketing Studies on Accelerated-Approval Cancer Drugs
Author(s) -
Peggy Eastman
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000395328.17429.6f
Subject(s) - drug approval , cancer drugs , medicine , cancer , pharmacology , drug